A recent paper by Kendra Sweet and Thomas Cluzeau was mentioned by Mohamed Benlazar, Professor of Hematology at Sidi Bel Abbès University Hospital, on X:
“Clinical perspectives on post-induction maintenance therapy in patients with AML in remission who are ineligible for allogeneic haematopoietic stem cell transplantation.”
Authors: Kendra Sweet and Thomas Cluzeau.
More posts featuring Mohamed Benlazar.
